Identification of <i>N</i>,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase InhibitorMaria Gabriella Brasca, Marina Ciomei, Nadia Amboldi et al.|Journal of Medicinal Chemistry|2009Cited by 128
Dual Targeting of CDK and Tropomyosin Receptor Kinase Families by the Oral Inhibitor PHA-848125, an Agent with Broad-Spectrum Antitumor EfficacyClara Albanese, Marina Ciomei, Wilma Pastori et al.|Molecular Cancer Therapeutics|2010Cited by 63
Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitorsElena Casale, Francesco Casuscelli, Nadia Amboldi et al.|Bioorganic & Medicinal Chemistry|2014Cited by 38
Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90)Maria Gabriella Brasca, Gianpaolo Fogliatto, Sergio Mantegani et al.|Bioorganic & Medicinal Chemistry|2013Cited by 36
Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disordersMaria Gabriella Brasca, Daniele Donati, Paola Gnocchi et al.|Bioorganic & Medicinal Chemistry|2015Cited by 20